MRK

MKT CAP:$284B

Merck & Company Inc

Market Cap

$284B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$119.46+$13.79 (+13.05%)

Jun 8, 2026

52W High $123.1852W Low $76.14

Company Details

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumov...

CEO

—

IPO Date

Jan 13, 1978

Website

www.merck.com

Key Metrics TTM

Revenue

$65.6B

+2.5% YoY

Net Income

$8.9B

EPS (Diluted)

Free Cash Flow

$14.1B

Revenue / Share

$26.53

Gross Margin

75.9%

Operating Margin

27.6%

Net Margin

13.6%

FCF Margin

21.5%

P/S

4.3x

P/E

31.8x

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 4, 2026

$16.3B+4.3%

FY 2025

Feb 24, 2026

$64.9B+1.2%

Q4 2025

Feb 24, 2026

$16.3B+4.5%

Q3 2025

Nov 5, 2025

$17.2B+3.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee